pharmaceutical investing Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra
medical device investing Arch Therapeutics to Provide Corporate Update at the Maxim Group – Haitong Securities Healthcare Investor and Partnering Conference
Factor Therapeutics Announces Commencement of Phase II Trial of a Novel Topical Biologic for the Treatment of Chronic Wounds
Element79 Gold Corp Announces Corporate Update and Strategic Leadership Changes With Focus On Accelerating Nevada Asset Development
